Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

To date, there are no biomarkers for major depressive disorder (MDD) treatment response in clinical use. Such biomarkers could allow for individualized treatment selection, reducing time spent on ineffective treatments and the burden of MDD. In search of such a biomarker, multisite pretreatment and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology
Hauptverfasser: Bartlett, Elizabeth A., DeLorenzo, Christine, Sharma, Priya, Yang, Jie, Zhang, Mengru, Petkova, Eva, Weissman, Myrna, McGrath, Patrick J., Fava, Maurizio, Ogden, R. Todd, Kurian, Benji T., Malchow, Ashley, Cooper, Crystal M., Trombello, Joseph M., McInnis, Melvin, Adams, Phillip, Oquendo, Maria A., Pizzagalli, Diego A., Trivedi, Madhukar, Parsey, Ramin V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135779/
https://ncbi.nlm.nih.gov/pubmed/29955151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0122-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge